BNT351 Clinical Trials (2026): 1 Studies for HIV -1 Infection
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 BNT351 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including HIV -1 Infection) and 61 total planned enrollment. 1 BNT351 clinical trial is actively recruiting at 1 U.S. site across 1 state. Most recent activity: NCT07392372 (Jun 2027).
Where to Participate: All BNT351 Trial Sites in the U.S. (1 site across 1 state)
Every actively recruiting BNT351trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| MD | Johns Hopkins | Baltimore21205-1832 | NCT07392372 | Map |
BNT351 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting BNT351 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07392372 | A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV | P1 | HIV -1 Infection | 61 | Feb 2026 |
All BNT351 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07392372 | A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV | P1 | recruiting | 61 | BioNTech SE | Feb 2026 |
BNT351 clinical trials: frequently asked questions
- How many BNT351 clinical trials are there?
- 1 BNT351 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are BNT351 clinical trials recruiting in 2026?
- Yes — 1 BNT351 trial is actively recruiting in 2026, with 1 U.S. site across 1 state. See the recruiting trials and the per-state site list further down this page.
- What conditions is BNT351 being studied for?
- BNT351 is being studied for HIV -1 Infection. The trials are grouped by indication on this page.
- What phase is BNT351 in?
- BNT351 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors BNT351 clinical trials?
- The lead sponsor across the most BNT351 trials is BioNTech SE. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming BNT351as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: